The effects appeared to rely on more than just improved in blood sugar control or weight reduction, the authors said, and ...

With only one approved drug on the market, companies like Inventiva Pharma are advancing MASH drugs and seeking a competitive ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

The effects appeared to rely on more than just improved in blood sugar control or weight reduction, the authors said, and ...

The effects appeared to rely on more than just improved in blood sugar control or weight reduction, the authors said, and ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

And actually, as the GLP-1s have actually continued to expand throughout the community, that’s where many of the initial ...

Robert F. Kennedy Jr.'s nomination to lead HHS is causing cautious concern among investors. Here's which companies and stocks ...

In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, and Intellia's promising ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...